Haleon plc (HLN)

NYSE: HLN · IEX Real-Time Price · USD
+0.01 (0.06%)
Apr 17, 2024, 3:40 PM EDT - Market open
Market Cap 37.01B
Revenue (ttm) 14.31B
Net Income (ttm) 1.33B
Shares Out 4.57B
EPS (ttm) 0.28
PE Ratio 28.67
Forward PE 37.04
Dividend $0.15 (1.85%)
Ex-Dividend Date Mar 14, 2024
Volume 2,898,863
Open 8.08
Previous Close 8.10
Day's Range 8.04 - 8.12
52-Week Range 7.70 - 9.05
Beta n/a
Analysts Strong Buy
Price Target 9.50 (+17.21%)
Earnings Date Feb 29, 2024

About HLN

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops,... [Read more]

Sector Healthcare
Founded 2022
Employees 25,408
Stock Exchange NYSE
Ticker Symbol HLN
Full Company Profile

Financial Performance

In 2023, Haleon's revenue was 11.30 billion, an increase of 4.09% compared to the previous year's 10.86 billion. Earnings were 1.05 billion, a decrease of -1.04%.

Financial numbers in GBP Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for HLN stock is "Strong Buy." The 12-month stock price forecast is $9.5, which is an increase of 17.21% from the latest price.

Price Target
(17.21% upside)
Analyst Consensus: Strong Buy
Stock Forecasts


Pfizer to Raise Around $4.27 Billion From Haleon Shares Sale

Pfizer is raising around $4.27 billion from the sale of part of its stake in consumer-healthcare business Haleon.

Other symbols: PFE
4 weeks ago - WSJ

Consumer healthcare giant Haleon says Pfizer to cut stake to 24%

Consumer healthcare giant Haleon said on Monday that Pfizer will sell about 630 million of its shares in the company, reducing the US drugmaker's stake to about 24%.

Other symbols: PFE
4 weeks ago - Reuters

Haleon CEO: We expect to see volume growth in 2024

Brian McNamara, CEO of Haleon, joins to discuss the firm's earnings. The consumer health company says it expects the operating environment to remain challenging, but is eyeing up to 6% organic revenue...

6 weeks ago - CNBC International TV

Haleon Shares Rise 5%+ As Strong FY Results Drive Share Buyback Scheme

FTSE 100-listed Haleon's share price leapt in Thursday trading, as strong sales growth and debt reduction in 2023 prompted it to launch a share repurchase programme.

6 weeks ago - Forbes

Consumer health giant Haleon sees higher revenue in 2024 on sustained demand

Sensodyne toothpaste-maker Haleon said on Thursday it expected higher revenue in 2024, thanks to firm demand for its household products ranging from painkillers to multivitamins.

6 weeks ago - Reuters

Abreva Drops One-of-a-Kind Pair of Diamond Lips, Inspired by the Cold Sore Experience

The leader in cold sore relief will shine a light on the condition, rewarding one cold sore sufferer with the limited edition, sparkling accessory. WARREN, N.J.

2 months ago - PRNewsWire

Haleon to recall batches of some adult cough syrups due to contamination

Haleon is recalling some lots of its adult cough syrup Robitussin because of microbial contamination, the U.S. Food and Drug Administration (FDA) has said.

2 months ago - Reuters

Haleon to sell ChapStick to Yellow Wood for about $510 million

Britain's Haleon said it had agreed to sell lip balm brand ChapStick to a company owned by private equity firm Yellow Wood Partners for around $430 million in cash and a stake valued at around $80 mil...

2 months ago - Reuters

Yellow Wood Partners Portfolio Company Suave Brands Company Acquires ChapStick from Haleon

BOSTON , Jan. 25, 2024 /PRNewswire/ -- Yellow Wood Partners ("Yellow Wood"), a Boston-based private equity firm focused on investing in consumer brands and companies, today announced that its portfoli...

2 months ago - PRNewsWire

New Research Affirms the Positive Impact of Centrum Silver on Memory in Older Adults

A third study from the COSMOS trial, COSMOS-Clinic, demonstrates consistent findings that taking Centrum Silver multivitamin daily benefits memory among older adults. WARREN, N.J.

3 months ago - PRNewsWire

TUMS® Teams Up with DraftKings and Desus Nice to Launch TUMS® Prop Bites, Allowing Big Game Fans to Go All In on Food for the First Time

TUMS® Prop Bites allows fans to decide which foods have won America's hearts and stomachs for a shot at a share of $10,000 prize pool WARREN, N.J. , Jan. 17, 2024 /PRNewswire/ -- In honor of the bigge...

3 months ago - PRNewsWire

GSK raises $1.24 bln from latest Haleon stake sale

British drugmaker GSK said on Wednesday it had raised 978 million pounds ($1.24 billion) from a discounted stake sale in Haleon , cutting its shareholding to 4.2% in the world's largest standalone con...

Other symbols: GSK
3 months ago - Reuters

GSK to sell 3.2% stake in spin-off Haleon

GSK will sell a 3.2% stake, or about 300 million shares, in its spun-off consumer healthcare business Haleon , the British drugmaker said on Tuesday.

Other symbols: GSK
3 months ago - Reuters

TUMS Partners with Designer Nik Bentel to Launch Limited Edition TUMS Bag to Fuse Food, Fashion and Heartburn Relief

The Official TUMS Bag is Available on Amazon and nikolasbentelstudio.com – Hurry, Before They Sell Out!  WARREN, N.J.

4 months ago - PRNewsWire

Health exclusion affects more than three in five people globally

Phase two of Economist Impact's Health Inclusivity Index, supported by Haleon, measures experience of health inclusion across 42,000 people in 40 countries Health inclusivity scores fall worldwide wit...

5 months ago - GlobeNewsWire

UK falls to third place in global Health Inclusivity Index

More than three in five (63%) people in the UK experience barriers to health inclusion People in UK, Canada and France face the longest waiting times to see a GP Health inclusivity scores fall worldwi...

5 months ago - GlobeNewsWire

Britain falls from top spot in Economist Impact's latest Health Inclusivity Index

The second phase of the index, supported by Haleon, assesses governments' efforts across 40 countries to ensure that good health is accessible to all individuals LONDON , Nov. 20, 2023 /PRNewswire/ --...

5 months ago - PRNewsWire

Advil maker Haleon's quarterly revenue rises on price hikes, strong demand

Consumer healthcare company Haleon posted higher third-quarter revenue and stuck by its full-year forecasts on Thursday, helped by price hikes and resilient demand for its painkillers, cold and flu ta...

5 months ago - Reuters

Sanofi to create its own Haleon, Kenvue as its stock price tumbles

Sanofi (FRA: SNW), the giant healthcare company, is considering spinning off its consumer health business. In a statement, the management said it was hoping to create a separate company listed in Fran...

Other symbols: KVUESNY
6 months ago - Invezz

Haleon (HLN) share price recovery faces one key hurdle

Haleon (LON: HLN) share price moved sideways this week after the company published its trading statement. The stock was trading at 340p on Wednesday, where it has been at in the past few days.

6 months ago - Invezz

GSK raises 886 mln pounds from Haleon stake sale

British drugmaker GSK on Friday said it raised 885.6 million pounds ($1.08 billion) from a stake sale in its spun-off consumer healthcare business Haleon at 328 pence a piece.

Other symbols: GSK
6 months ago - Reuters

GSK to sell 2.9% stake in former consumer healthcare business Haleon

GSK intends to sell a 2.9% stake, or about 270 million shares, in its spun-off consumer healthcare business Haleon , the British drugmaker said on Thursday.

Other symbols: GSK
6 months ago - Reuters

New global study discovers people in pain feel more socially excluded than ever

LONDON, Sept. 28, 2023 (GLOBE NEWSWIRE) -- A new study of 18,097 people across 18 countries has discovered that society has grown less tolerant of people in pain, despite the effects of COVID-19 boost...

7 months ago - GlobeNewsWire

Haleon Upgrades Full-Year Sales Forecasts As Recent Trading Impresses

The FTSE 100 healthcare firm said that revenues increased 10.6% in the first half, while pre-tax profit increased 11.1% year on year.

9 months ago - Forbes

Haleon raises annual organic revenue growth forecast on steady demand

Haleon on Wednesday raised its forecast for annual organic revenue growth as the consumer healthcare company is confident that demand for its oral and respiratory health products will stick despite a ...

9 months ago - Reuters